K-V Pharmaceutical Co – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Late annual filing notification for FY 2013

Late quarterly filing notification for Q3 2013

Late quarterly filing notification for Q2 2013

Late quarterly filing notification for Q1 2013

ended 03/31/12 FY 2012

Prospectuses and Registrations Filter

Securities registration termination

Securities registration termination

Exempt offering of securities

Removal from listing

Registration withdrawal request

Ownership Filter

Vergis Janet S.

Goldfarb James M.

Christmas Patrick J.

News Filter

Completes New Board With Appointment of Former Johnson & Johnson Executive

Appoints Two New Board Members

Appoints Former Wyeth Pharmaceuticals President, Joe Mahady to Chairman of the Board

Completes Reorganization and Successfully Emerges From Chapter 11 With $375 Million Recapitalization

Completes Reorganization and Successfully Emerges From Chapter 11 With $375 Million Recapitalization

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC